Related Experiment Video
Updated: Mar 30, 2026
06:40
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
1.9K
Large-Scale Drug Screens Support Precision Medicine
1Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. grayjo@ohsu.edu.
Cancer Discovery
|November 4, 2015
Summary
Researchers mapped cancer cell line responses to hundreds of drugs to identify effective precision cancer medicines. This work aids in matching specific cancer subtypes with targeted therapies for better patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Computational Biology
Background:
- Precision medicine aims to link cancer subtypes with targeted drugs for improved patient outcomes and reduced toxicity.
- A significant challenge is identifying which drugs are effective against specific cancer subsets.
Discussion:
- Seashore-Ludlow and colleagues measured the responses of 664 adherent cancer cell lines to 70 FDA-approved drugs, 100 experimental compounds, and 311 small-molecule probes.
- A novel Annotated Cluster Multidimensional Enrichment algorithm was employed to analyze the drug response data.
Key Insights:
- The study identified drug mechanisms of action and molecular markers associated with drug response.
- Specific cancer subtypes responsive to particular drugs were elucidated.
- Compounds demonstrating synergistic effects on cancer cell inhibition were pinpointed.
Outlook:
- This research provides a valuable resource for advancing precision oncology by facilitating the matching of patients with the most effective treatments.
- The findings support the development of novel therapeutic strategies and drug combinations for various cancer types.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
77
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
77
02:46Genetic Screens
5.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K
01:26Drug Discovery: Overview
13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
01:29Pharmacogenetics and Pharmacogenomics: Overview
144
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
144
01:27Pharmacogenetics of Drug Metabolism: Overview
113
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
113
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
109
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109